Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Dhanvantri Jeevan Rekha's Enterprise Value is ₹59.5 Mil.
Dhanvantri Jeevan Rekha's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0.0 Mil. Therefore, Dhanvantri Jeevan Rekha's EV-to-FCF for today is .
The historical rank and industry rank for Dhanvantri Jeevan Rekha's EV-to-FCF or its related term are showing as below:
BOM:531043'
s EV-to-FCF Range Over the Past 10 Years
Min: 0 Med: 0 Max: 7.69
Current: 7.69
During the past 13 years, the highest EV-to-FCF of Dhanvantri Jeevan Rekha was 7.69. The lowest was 0.00. And the median was 0.00.
BOM:531043's EV-to-FCF is ranked better than 79.51% of 405
companies
in the Healthcare Providers & Services industry
Industry Median: 17.83
vs BOM:531043: 7.69
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Dhanvantri Jeevan Rekha's PE Ratio (TTM) for today is calculated as:
Dhanvantri Jeevan Rekha's share price for today is ₹23.55.
Dhanvantri Jeevan Rekha's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.940.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Dhanvantri Jeevan Rekha's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dhanvantri Jeevan Rekha EV-to-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Dhanvantri Jeevan Rekha's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Dhanvantri Jeevan Rekha's EV-to-FCF falls into.
Dhanvantri Jeevan Rekha's current Enterprise Value is ₹59.5 Mil.
Dhanvantri Jeevan Rekha's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Is Dhanvantri Jeevan Rekha (BOM:531043) Overvalued in 2026?
Based on GuruFocus' analysis, Dhanvantri Jeevan Rekha stock appears to be undervalued.
The current stock price of ₹23.55 is trading 6.3% below its estimated GF Value™ of ₹25.12.
GuruFocus considers Dhanvantri Jeevan Rekha to be Fairly Valued.
Key valuation signals for BOM:531043:
EV-to-FCF:
GF Value™: ₹25.12 vs. price of ₹23.55 (6.3% below fair value)
No single metric tells the full story. See the BOM:531043 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dhanvantri Jeevan Rekha Ltd is engaged in providing diagnostic and therapeutic services and has extended its scope of diagnostic and hospital services by providing a fully operational Cath Lab, catering to higher end needs of the cardiac patients including Angiography, Angioplasty, Pacemaker Implantation, Valvuloplasty etc. The hospital has expanded its services to include a wide range of specialties such as Cardiology, Neurology, Orthopedics, Radiology, Gastroenterology, General Surgery, Urology, and General Medicine.
64GF Score
Get the complete analysis for BOM:531043
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:531043 has been successfully added to your 
